Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 545 results for "pharma"

'Hidden' nexus between pharma cos and doctors under scanner
The Assam Tribune

'Hidden' nexus between pharma cos and doctors under scanner

GUWAHATI, Oct 19 - For doctors, it starts with teasers like pens and diaries. And once the rapport improves, the noted ones are even offered an all-expenses-paid trip to their dream overseas destination, mostly shown as personal or pleasure trip in the State ... The Assam Tribune, 3 hours ago

257 images for pharma

Money Control, 1 day ago
Money Control, 2 days ago
Money Control, 2 days ago
Money Control, 3 days ago
Money Control, 4 days ago
Money Control, 6 days ago
Money Control, 6 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control

AstraZeneca Pharma rallies 4% on permission from drug controller to market diabetes drug

The drug firm has received marketing authorisation from the Drug Controller General of India (DCGI) for Xigduo XR tablets used in the treatment of adults with type 2 diabetes in India.
 Money Control1 day ago AstraZeneca Pharma India gets DCGI nod to market diabetes drug  Money Control2 days ago Pharma company Lupin gets USFDA go-ahead to market generic anti-bacterial drug  DNA1 month ago AstraZeneca gains after getting approval for diabetes drug  Business Standard1 day ago

Lincoln Pharma in pink of health after incorporating subsidiary

after the company said that it has incorporated wholly owned subsidiary company, Savebux Finance & Investment in India. The announcement was made during market hours today, 18 October 2017. Meanwhile, the BSE Sensex was up 40.11 points, or 0.12%, to ...
 Business Standard1 day ago
Money Control

Aurobindo Pharma gets USFDA nod for heartburn drug

Aurobindo Pharma has received final approval from the US health regulator to manufacture Esomeprazole Magnesium delayed-release capsules, used in treatment of frequent heartburn, in the US market.In a BSE filing, Aurobindo Pharma said it "has received final ...
 Business Standard2 days ago Aurobindo Pharma receives final approval for Esomeprazole Magnesium Delayed-Release Capsules  Business Standard2 days ago Aurobindo Pharma gets healthier after USFDA nod for drug  Business Standard2 days ago Aurobindo Pharma rises 2% on USFDA final nod for Esomeprazole capsules  Money Control2 days ago
[x]  
Money Control

Sun Pharma gains 4% on EIR from USFDA for Dadra facility

EIR indicates closure of plant inspection by the US regulatory agency.
 Money Control1 week ago Sun Pharma gains 4% as Dadra plant gets EIR from USFDA  Business Standard1 week ago US FDA clears Sun Pharma's Dadra plant  Business Standard1 week ago Sun Pharmaceutical gets USFDA inspection report for Dadra facility  Business Standard1 week ago
[x]  
Money Control

Market Live: Sensex gains strength again, Nifty above 10,200; pharma rallies

Nifty Midcap was up 0.6 percent or 115 points in early trade on strong market breadth.
 Money Control3 days ago Market Update: Nifty above 10K; Bharti Infratel hits 1-yr high, Hindalco, Auro Pharma top gainers  Money Control1 week ago Market Live: Nifty opens above 10K, Sensex mildly higher; Sun Pharma top gainer  Money Control1 week ago Market Live: Sensex, Nifty, Midcap off day#39;s highs; HPCL, BPCL, IOC erase gains  Money Control1 month ago
Money Control

Market at record closing high; Nifty above 10,200, Sensex gains 201 pts; Airtel up 5%

Nifty Auto, Metal, pharma and Realty indices gained 1-2 percent while Nifty Bank ended flat and PSU Bank was down 0.2 percent.
 Money Control3 days ago Closing Bell: Sensex ends over 300 pts higher, Nifty ends around 10,100; metals gain  Money Control1 week ago Closing Bell: Nifty, Sensex close at day#39;s high; Metals, PSU banks outperform  Money Control1 week ago Sensex sinks 440 pts to end at 3-month low; Nifty sub-9800 ahead of FO expiry  Money Control3 weeks ago
[x]  
Money Control

Buy Ajanta Pharma; target of Rs 1605: Motilal Oswal

Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1605 in its research report dated October 12, 2017.
 Money Control6 days ago Buy Natco Pharma; target of Rs 1240: Axis Direct  Money Control6 days ago Torrent Pharma upgraded to add from ‘hold’; target price at Rs 1,374: ICICI Securities  Money Control1 week ago Buy Torrent Pharma; target of Rs 1450: Reliance Securities  Money Control1 month ago
Money Control

Nifty likely to open lower with crucial support at 10150; buy Sun Pharma, Tata Motors: Prakash Gaba

According to Technical Analyst Prakash Gaba of prakashgaba.com, the crucial support for the Nifty is at 10150 and the resistance is at 10315-10537. On the other hand, Bank Nifty has support at 25000 and resistance at 24534.
 Money Control3 days ago Nifty likely to open lower, crucial support at 10022; buy Sun Pharma, REC  Money Control1 month ago

Stocks in the news: Sun Pharma, Wipro, Axis Bank, Power Grid, Arvind, Claris Life

Sun Pharma | Wipro | Axis Bank | Nucleus Software | Blue Dart | Tata Sponge | Jubilant Life | Power Grid | Astrazeneca | Nila Infra | Arvind | Claris Life | Sutlej and JBF Industries are stocks, which are in the news today.
 Money Control2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less